Generic Engineering Construction does not approve FY26 results
Generic Engineering Construction and Projects Limited did not approve the audited financial results for FY26 during a meeting scheduled under Regulation 33 on May 29, 2026. The Board convened the session to consider the accounts for the fiscal year ending March 31, 2026, but did not grant approval. Further announcements are awaited regarding the status of the financial results.

*this image is generated using AI for illustrative purposes only.
Generic Engineering Construction and Projects Limited did not approve the audited financial results for FY26 during a meeting scheduled under Regulation 33 on May 29, 2026. The company had convened the meeting to consider and approve the financial statements for the fiscal year ending March 31, 2026.
The regulatory filing indicates that the Board did not grant approval for the audited results during the proceedings. The specific reasons for the non-approval were not detailed in the disclosure provided. The meeting was held in accordance with the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Results Status
The company has yet to finalize and release the audited financial results for FY26. The status of the financial results is summarized below:
| Parameter | Status |
|---|---|
| Fiscal Year | FY26 |
| Meeting Date | May 29, 2026 |
| Regulation | Regulation 33 |
| Outcome | Non-approval of audited results |
Shareholders and investors are advised to await further regulatory intimations from the company regarding the rescheduling of the approval process or the finalization of the financial statements.
Historical Stock Returns for Generic Engineering Construction
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.49% | -3.00% | -3.65% | -12.77% | -7.73% | -13.70% |
What are the potential regulatory penalties or compliance issues the company might face if the delay in finalizing audited results persists?
How might this delay impact investor confidence and the stock's liquidity in the short term?
What specific concerns could the Board have regarding the financial statements that prevented approval?


































